US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59

The U.S. Food and Drug Administration
approved the expanded use of GSK's respiratory syncytial
virus vaccine on Friday in adults aged between 50 and 59, making
it the first shot endorsed for that age...

Related Keywords

Bengaluru ,Karnataka ,India ,Christy Santhosh ,Sriparna Roy ,Vijay Kishore ,Puyaan Singh ,Pooja Desai ,Drug Administration ,Reuters ,Pfizer ,